Global Tafasitamab Market Growth 2026-2032
The global Tafasitamab market size is predicted to grow from US$ 333 million in 2025 to US$ 802 million in 2032; it is expected to grow at a CAGR of 12.2% from 2026 to 2032.
Tafasitamab is a humanized CD19-targeted monoclonal antibody primarily used in the treatment of B-cell malignancies. It specifically binds to the CD19 antigen expressed on the surface of B cells, inducing antibody-dependent cellular cytotoxicity (ADCC) and other immune-mediated mechanisms, thereby promoting the elimination of malignant B cells. Tafasitamab is typically used in combination with immunomodulatory agents such as lenalidomide for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It has significant clinical value in the field of hematologic cancer targeted therapy.In 2025, global production of tafasitamab reached approximately 150,000units.
Tafasitamab, as a CD19-targeted monoclonal antibody, occupies an important niche in the treatment market for B-cell non-Hodgkin lymphoma, particularly in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). With the steady increase in the global incidence of hematologic malignancies and the growing demand for novel immuno-targeted therapies, the CD19-targeted drug market is gradually expanding. Tafasitamab has demonstrated clinical efficacy in combination with lenalidomide, enabling it to gain guideline recommendations and improve its clinical penetration. From a competitive landscape perspective, this field is not only dominated by long-established CD20 monoclonal antibodies such as rituximab, but also faces competitive pressure from emerging CD19/CD79b-targeted therapies. Looking ahead, with the accumulation of real-world evidence, expansion of indications, and commercialization in emerging markets, the market size of tafasitamab is expected to maintain steady growth, continuing to play an important role in the precision treatment landscape of B-cell lymphoma.
LP Information, Inc. (LPI) ' newest research report, the ?Tafasitamab Industry Forecast? looks at past sales and reviews total world Tafasitamab sales in 2025, providing a comprehensive analysis by region and market sector of projected Tafasitamab sales for 2026 through 2032. With Tafasitamab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tafasitamab industry.
This Insight Report provides a comprehensive analysis of the global Tafasitamab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tafasitamab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tafasitamab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tafasitamab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tafasitamab.
This report presents a comprehensive overview, market shares, and growth opportunities of Tafasitamab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Tafasitamab market?
What factors are driving Tafasitamab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tafasitamab market opportunities vary by end market size?
How does Tafasitamab break out by Type, by Application?
Tafasitamab is a humanized CD19-targeted monoclonal antibody primarily used in the treatment of B-cell malignancies. It specifically binds to the CD19 antigen expressed on the surface of B cells, inducing antibody-dependent cellular cytotoxicity (ADCC) and other immune-mediated mechanisms, thereby promoting the elimination of malignant B cells. Tafasitamab is typically used in combination with immunomodulatory agents such as lenalidomide for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). It has significant clinical value in the field of hematologic cancer targeted therapy.In 2025, global production of tafasitamab reached approximately 150,000units.
Tafasitamab, as a CD19-targeted monoclonal antibody, occupies an important niche in the treatment market for B-cell non-Hodgkin lymphoma, particularly in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). With the steady increase in the global incidence of hematologic malignancies and the growing demand for novel immuno-targeted therapies, the CD19-targeted drug market is gradually expanding. Tafasitamab has demonstrated clinical efficacy in combination with lenalidomide, enabling it to gain guideline recommendations and improve its clinical penetration. From a competitive landscape perspective, this field is not only dominated by long-established CD20 monoclonal antibodies such as rituximab, but also faces competitive pressure from emerging CD19/CD79b-targeted therapies. Looking ahead, with the accumulation of real-world evidence, expansion of indications, and commercialization in emerging markets, the market size of tafasitamab is expected to maintain steady growth, continuing to play an important role in the precision treatment landscape of B-cell lymphoma.
LP Information, Inc. (LPI) ' newest research report, the ?Tafasitamab Industry Forecast? looks at past sales and reviews total world Tafasitamab sales in 2025, providing a comprehensive analysis by region and market sector of projected Tafasitamab sales for 2026 through 2032. With Tafasitamab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tafasitamab industry.
This Insight Report provides a comprehensive analysis of the global Tafasitamab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tafasitamab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Tafasitamab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tafasitamab and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tafasitamab.
This report presents a comprehensive overview, market shares, and growth opportunities of Tafasitamab market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Combination With Immunomodulatory Agents (Such As Lenalidomide)
- Combination With Chemotherapy Or Other Targeted Therapies
- 200 mg / vial
- 800 mg/vial
- Innovator
- Generic
- Lyophilized Powder for Injection
- Injection Solution
- Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
- B-Cell Non-Hodgkin Lymphoma (B-NHL)
- CD19-Positive Hematologic Malignancies
- Precision Hematologic Cancer Therapy
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- MorphoSys AG
- Incyte Corporation
What is the 10-year outlook for the global Tafasitamab market?
What factors are driving Tafasitamab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tafasitamab market opportunities vary by end market size?
How does Tafasitamab break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tafasitamab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tafasitamab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tafasitamab by Country/Region, 2021, 2025 & 2032
2.2 Tafasitamab Segment by Type
2.2.1 Combination With Immunomodulatory Agents (Such As Lenalidomide)
2.2.2 Combination With Chemotherapy Or Other Targeted Therapies
2.2.3 Tafasitamab Sales by Type
2.2.3.1 Global Tafasitamab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Tafasitamab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Tafasitamab Sale Price by Type (2021-2026)
2.3 Tafasitamab Segment by Specification
2.3.1 200 mg / vial
2.3.2 800 mg/vial
2.3.3 Tafasitamab Sales by Specification
2.3.3.1 Global Tafasitamab Sales Market Share by Specification (2021-2026)
2.3.3.2 Global Tafasitamab Revenue and Market Share by Specification (2021-2026)
2.3.3.3 Global Tafasitamab Sale Price by Specification (2021-2026)
2.4 Tafasitamab Segment by Production Technology
2.4.1 Innovator
2.4.2 Generic
2.4.3 Tafasitamab Sales by Production Technology
2.4.3.1 Global Tafasitamab Sales Market Share by Production Technology (2021-2026)
2.4.3.2 Global Tafasitamab Revenue and Market Share by Production Technology (2021-2026)
2.4.3.3 Global Tafasitamab Sale Price by Production Technology (2021-2026)
2.5 Tafasitamab Segment by Dosage Form
2.5.1 Lyophilized Powder for Injection
2.5.2 Injection Solution
2.5.3 Tafasitamab Sales by Dosage Form
2.5.3.1 Global Tafasitamab Sales Market Share by Dosage Form (2021-2026)
2.5.3.2 Global Tafasitamab Revenue and Market Share by Dosage Form (2021-2026)
2.5.3.3 Global Tafasitamab Sale Price by Dosage Form (2021-2026)
2.6 Tafasitamab Segment by Application
2.6.1 Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
2.6.2 B-Cell Non-Hodgkin Lymphoma (B-NHL)
2.6.3 CD19-Positive Hematologic Malignancies
2.6.4 Precision Hematologic Cancer Therapy
2.6.5 Others
2.6.6 Tafasitamab Sales by Application
2.6.6.1 Global Tafasitamab Sale Market Share by Application (2021-2026)
2.6.6.2 Global Tafasitamab Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Tafasitamab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tafasitamab Breakdown Data by Company
3.1.1 Global Tafasitamab Annual Sales by Company (2021-2026)
3.1.2 Global Tafasitamab Sales Market Share by Company (2021-2026)
3.2 Global Tafasitamab Annual Revenue by Company (2021-2026)
3.2.1 Global Tafasitamab Revenue by Company (2021-2026)
3.2.2 Global Tafasitamab Revenue Market Share by Company (2021-2026)
3.3 Global Tafasitamab Sale Price by Company
3.4 Key Manufacturers Tafasitamab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tafasitamab Product Location Distribution
3.4.2 Players Tafasitamab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TAFASITAMAB BY GEOGRAPHIC REGION
4.1 World Historic Tafasitamab Market Size by Geographic Region (2021-2026)
4.1.1 Global Tafasitamab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tafasitamab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tafasitamab Market Size by Country/Region (2021-2026)
4.2.1 Global Tafasitamab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tafasitamab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tafasitamab Sales Growth
4.4 APAC Tafasitamab Sales Growth
4.5 Europe Tafasitamab Sales Growth
4.6 Middle East & Africa Tafasitamab Sales Growth
5 AMERICAS
5.1 Americas Tafasitamab Sales by Country
5.1.1 Americas Tafasitamab Sales by Country (2021-2026)
5.1.2 Americas Tafasitamab Revenue by Country (2021-2026)
5.2 Americas Tafasitamab Sales by Type (2021-2026)
5.3 Americas Tafasitamab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tafasitamab Sales by Region
6.1.1 APAC Tafasitamab Sales by Region (2021-2026)
6.1.2 APAC Tafasitamab Revenue by Region (2021-2026)
6.2 APAC Tafasitamab Sales by Type (2021-2026)
6.3 APAC Tafasitamab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tafasitamab by Country
7.1.1 Europe Tafasitamab Sales by Country (2021-2026)
7.1.2 Europe Tafasitamab Revenue by Country (2021-2026)
7.2 Europe Tafasitamab Sales by Type (2021-2026)
7.3 Europe Tafasitamab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tafasitamab by Country
8.1.1 Middle East & Africa Tafasitamab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tafasitamab Revenue by Country (2021-2026)
8.2 Middle East & Africa Tafasitamab Sales by Type (2021-2026)
8.3 Middle East & Africa Tafasitamab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tafasitamab
10.3 Manufacturing Process Analysis of Tafasitamab
10.4 Industry Chain Structure of Tafasitamab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tafasitamab Distributors
11.3 Tafasitamab Customer
12 WORLD FORECAST REVIEW FOR TAFASITAMAB BY GEOGRAPHIC REGION
12.1 Global Tafasitamab Market Size Forecast by Region
12.1.1 Global Tafasitamab Forecast by Region (2027-2032)
12.1.2 Global Tafasitamab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tafasitamab Forecast by Type (2027-2032)
12.7 Global Tafasitamab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MorphoSys AG
13.1.1 MorphoSys AG Company Information
13.1.2 MorphoSys AG Tafasitamab Product Portfolios and Specifications
13.1.3 MorphoSys AG Tafasitamab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MorphoSys AG Main Business Overview
13.1.5 MorphoSys AG Latest Developments
13.2 Incyte Corporation
13.2.1 Incyte Corporation Company Information
13.2.2 Incyte Corporation Tafasitamab Product Portfolios and Specifications
13.2.3 Incyte Corporation Tafasitamab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Incyte Corporation Main Business Overview
13.2.5 Incyte Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tafasitamab Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Tafasitamab by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Tafasitamab by Country/Region, 2021, 2025 & 2032
2.2 Tafasitamab Segment by Type
2.2.1 Combination With Immunomodulatory Agents (Such As Lenalidomide)
2.2.2 Combination With Chemotherapy Or Other Targeted Therapies
2.2.3 Tafasitamab Sales by Type
2.2.3.1 Global Tafasitamab Sales Market Share by Type (2021-2026)
2.2.3.2 Global Tafasitamab Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Tafasitamab Sale Price by Type (2021-2026)
2.3 Tafasitamab Segment by Specification
2.3.1 200 mg / vial
2.3.2 800 mg/vial
2.3.3 Tafasitamab Sales by Specification
2.3.3.1 Global Tafasitamab Sales Market Share by Specification (2021-2026)
2.3.3.2 Global Tafasitamab Revenue and Market Share by Specification (2021-2026)
2.3.3.3 Global Tafasitamab Sale Price by Specification (2021-2026)
2.4 Tafasitamab Segment by Production Technology
2.4.1 Innovator
2.4.2 Generic
2.4.3 Tafasitamab Sales by Production Technology
2.4.3.1 Global Tafasitamab Sales Market Share by Production Technology (2021-2026)
2.4.3.2 Global Tafasitamab Revenue and Market Share by Production Technology (2021-2026)
2.4.3.3 Global Tafasitamab Sale Price by Production Technology (2021-2026)
2.5 Tafasitamab Segment by Dosage Form
2.5.1 Lyophilized Powder for Injection
2.5.2 Injection Solution
2.5.3 Tafasitamab Sales by Dosage Form
2.5.3.1 Global Tafasitamab Sales Market Share by Dosage Form (2021-2026)
2.5.3.2 Global Tafasitamab Revenue and Market Share by Dosage Form (2021-2026)
2.5.3.3 Global Tafasitamab Sale Price by Dosage Form (2021-2026)
2.6 Tafasitamab Segment by Application
2.6.1 Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
2.6.2 B-Cell Non-Hodgkin Lymphoma (B-NHL)
2.6.3 CD19-Positive Hematologic Malignancies
2.6.4 Precision Hematologic Cancer Therapy
2.6.5 Others
2.6.6 Tafasitamab Sales by Application
2.6.6.1 Global Tafasitamab Sale Market Share by Application (2021-2026)
2.6.6.2 Global Tafasitamab Revenue and Market Share by Application (2021-2026)
2.6.6.3 Global Tafasitamab Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Tafasitamab Breakdown Data by Company
3.1.1 Global Tafasitamab Annual Sales by Company (2021-2026)
3.1.2 Global Tafasitamab Sales Market Share by Company (2021-2026)
3.2 Global Tafasitamab Annual Revenue by Company (2021-2026)
3.2.1 Global Tafasitamab Revenue by Company (2021-2026)
3.2.2 Global Tafasitamab Revenue Market Share by Company (2021-2026)
3.3 Global Tafasitamab Sale Price by Company
3.4 Key Manufacturers Tafasitamab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tafasitamab Product Location Distribution
3.4.2 Players Tafasitamab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TAFASITAMAB BY GEOGRAPHIC REGION
4.1 World Historic Tafasitamab Market Size by Geographic Region (2021-2026)
4.1.1 Global Tafasitamab Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Tafasitamab Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Tafasitamab Market Size by Country/Region (2021-2026)
4.2.1 Global Tafasitamab Annual Sales by Country/Region (2021-2026)
4.2.2 Global Tafasitamab Annual Revenue by Country/Region (2021-2026)
4.3 Americas Tafasitamab Sales Growth
4.4 APAC Tafasitamab Sales Growth
4.5 Europe Tafasitamab Sales Growth
4.6 Middle East & Africa Tafasitamab Sales Growth
5 AMERICAS
5.1 Americas Tafasitamab Sales by Country
5.1.1 Americas Tafasitamab Sales by Country (2021-2026)
5.1.2 Americas Tafasitamab Revenue by Country (2021-2026)
5.2 Americas Tafasitamab Sales by Type (2021-2026)
5.3 Americas Tafasitamab Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tafasitamab Sales by Region
6.1.1 APAC Tafasitamab Sales by Region (2021-2026)
6.1.2 APAC Tafasitamab Revenue by Region (2021-2026)
6.2 APAC Tafasitamab Sales by Type (2021-2026)
6.3 APAC Tafasitamab Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tafasitamab by Country
7.1.1 Europe Tafasitamab Sales by Country (2021-2026)
7.1.2 Europe Tafasitamab Revenue by Country (2021-2026)
7.2 Europe Tafasitamab Sales by Type (2021-2026)
7.3 Europe Tafasitamab Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tafasitamab by Country
8.1.1 Middle East & Africa Tafasitamab Sales by Country (2021-2026)
8.1.2 Middle East & Africa Tafasitamab Revenue by Country (2021-2026)
8.2 Middle East & Africa Tafasitamab Sales by Type (2021-2026)
8.3 Middle East & Africa Tafasitamab Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tafasitamab
10.3 Manufacturing Process Analysis of Tafasitamab
10.4 Industry Chain Structure of Tafasitamab
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tafasitamab Distributors
11.3 Tafasitamab Customer
12 WORLD FORECAST REVIEW FOR TAFASITAMAB BY GEOGRAPHIC REGION
12.1 Global Tafasitamab Market Size Forecast by Region
12.1.1 Global Tafasitamab Forecast by Region (2027-2032)
12.1.2 Global Tafasitamab Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Tafasitamab Forecast by Type (2027-2032)
12.7 Global Tafasitamab Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 MorphoSys AG
13.1.1 MorphoSys AG Company Information
13.1.2 MorphoSys AG Tafasitamab Product Portfolios and Specifications
13.1.3 MorphoSys AG Tafasitamab Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 MorphoSys AG Main Business Overview
13.1.5 MorphoSys AG Latest Developments
13.2 Incyte Corporation
13.2.1 Incyte Corporation Company Information
13.2.2 Incyte Corporation Tafasitamab Product Portfolios and Specifications
13.2.3 Incyte Corporation Tafasitamab Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Incyte Corporation Main Business Overview
13.2.5 Incyte Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tafasitamab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tafasitamab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Combination With Immunomodulatory Agents (Such As Lenalidomide)
Table 4. Major Players of Combination With Chemotherapy Or Other Targeted Therapies
Table 5. Global Tafasitamab Sales by Type (2021-2026) & (Units)
Table 6. Global Tafasitamab Sales Market Share by Type (2021-2026)
Table 7. Global Tafasitamab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Tafasitamab Revenue Market Share by Type (2021-2026)
Table 9. Global Tafasitamab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 200 mg / vial
Table 11. Major Players of 800 mg/vial
Table 12. Global Tafasitamab Sales by Specification (2021-2026) & (Units)
Table 13. Global Tafasitamab Sales Market Share by Specification (2021-2026)
Table 14. Global Tafasitamab Revenue by Specification (2021-2026) & ($ million)
Table 15. Global Tafasitamab Revenue Market Share by Specification (2021-2026)
Table 16. Global Tafasitamab Sale Price by Specification (2021-2026) & (US$/Unit)
Table 17. Major Players of Innovator
Table 18. Major Players of Generic
Table 19. Global Tafasitamab Sales by Production Technology (2021-2026) & (Units)
Table 20. Global Tafasitamab Sales Market Share by Production Technology (2021-2026)
Table 21. Global Tafasitamab Revenue by Production Technology (2021-2026) & ($ million)
Table 22. Global Tafasitamab Revenue Market Share by Production Technology (2021-2026)
Table 23. Global Tafasitamab Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 24. Major Players of Lyophilized Powder for Injection
Table 25. Major Players of Injection Solution
Table 26. Global Tafasitamab Sales by Dosage Form (2021-2026) & (Units)
Table 27. Global Tafasitamab Sales Market Share by Dosage Form (2021-2026)
Table 28. Global Tafasitamab Revenue by Dosage Form (2021-2026) & ($ million)
Table 29. Global Tafasitamab Revenue Market Share by Dosage Form (2021-2026)
Table 30. Global Tafasitamab Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 31. Global Tafasitamab Sale by Application (2021-2026) & (Units)
Table 32. Global Tafasitamab Sale Market Share by Application (2021-2026)
Table 33. Global Tafasitamab Revenue by Application (2021-2026) & ($ million)
Table 34. Global Tafasitamab Revenue Market Share by Application (2021-2026)
Table 35. Global Tafasitamab Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Tafasitamab Sales by Company (2021-2026) & (Units)
Table 37. Global Tafasitamab Sales Market Share by Company (2021-2026)
Table 38. Global Tafasitamab Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Tafasitamab Revenue Market Share by Company (2021-2026)
Table 40. Global Tafasitamab Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Tafasitamab Producing Area Distribution and Sales Area
Table 42. Players Tafasitamab Products Offered
Table 43. Tafasitamab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Tafasitamab Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global Tafasitamab Sales Market Share Geographic Region (2021-2026)
Table 48. Global Tafasitamab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Tafasitamab Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Tafasitamab Sales by Country/Region (2021-2026) & (Units)
Table 51. Global Tafasitamab Sales Market Share by Country/Region (2021-2026)
Table 52. Global Tafasitamab Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Tafasitamab Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Tafasitamab Sales by Country (2021-2026) & (Units)
Table 55. Americas Tafasitamab Sales Market Share by Country (2021-2026)
Table 56. Americas Tafasitamab Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Tafasitamab Sales by Type (2021-2026) & (Units)
Table 58. Americas Tafasitamab Sales by Application (2021-2026) & (Units)
Table 59. APAC Tafasitamab Sales by Region (2021-2026) & (Units)
Table 60. APAC Tafasitamab Sales Market Share by Region (2021-2026)
Table 61. APAC Tafasitamab Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Tafasitamab Sales by Type (2021-2026) & (Units)
Table 63. APAC Tafasitamab Sales by Application (2021-2026) & (Units)
Table 64. Europe Tafasitamab Sales by Country (2021-2026) & (Units)
Table 65. Europe Tafasitamab Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Tafasitamab Sales by Type (2021-2026) & (Units)
Table 67. Europe Tafasitamab Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa Tafasitamab Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa Tafasitamab Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Tafasitamab Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa Tafasitamab Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of Tafasitamab
Table 73. Key Market Challenges & Risks of Tafasitamab
Table 74. Key Industry Trends of Tafasitamab
Table 75. Tafasitamab Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Tafasitamab Distributors List
Table 78. Tafasitamab Customer List
Table 79. Global Tafasitamab Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global Tafasitamab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Tafasitamab Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas Tafasitamab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Tafasitamab Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC Tafasitamab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Tafasitamab Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe Tafasitamab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Tafasitamab Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa Tafasitamab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Tafasitamab Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global Tafasitamab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Tafasitamab Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global Tafasitamab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. MorphoSys AG Basic Information, Tafasitamab Manufacturing Base, Sales Area and Its Competitors
Table 94. MorphoSys AG Tafasitamab Product Portfolios and Specifications
Table 95. MorphoSys AG Tafasitamab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. MorphoSys AG Main Business
Table 97. MorphoSys AG Latest Developments
Table 98. Incyte Corporation Basic Information, Tafasitamab Manufacturing Base, Sales Area and Its Competitors
Table 99. Incyte Corporation Tafasitamab Product Portfolios and Specifications
Table 100. Incyte Corporation Tafasitamab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Incyte Corporation Main Business
Table 102. Incyte Corporation Latest Developments
Table 1. Tafasitamab Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Tafasitamab Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Combination With Immunomodulatory Agents (Such As Lenalidomide)
Table 4. Major Players of Combination With Chemotherapy Or Other Targeted Therapies
Table 5. Global Tafasitamab Sales by Type (2021-2026) & (Units)
Table 6. Global Tafasitamab Sales Market Share by Type (2021-2026)
Table 7. Global Tafasitamab Revenue by Type (2021-2026) & ($ million)
Table 8. Global Tafasitamab Revenue Market Share by Type (2021-2026)
Table 9. Global Tafasitamab Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of 200 mg / vial
Table 11. Major Players of 800 mg/vial
Table 12. Global Tafasitamab Sales by Specification (2021-2026) & (Units)
Table 13. Global Tafasitamab Sales Market Share by Specification (2021-2026)
Table 14. Global Tafasitamab Revenue by Specification (2021-2026) & ($ million)
Table 15. Global Tafasitamab Revenue Market Share by Specification (2021-2026)
Table 16. Global Tafasitamab Sale Price by Specification (2021-2026) & (US$/Unit)
Table 17. Major Players of Innovator
Table 18. Major Players of Generic
Table 19. Global Tafasitamab Sales by Production Technology (2021-2026) & (Units)
Table 20. Global Tafasitamab Sales Market Share by Production Technology (2021-2026)
Table 21. Global Tafasitamab Revenue by Production Technology (2021-2026) & ($ million)
Table 22. Global Tafasitamab Revenue Market Share by Production Technology (2021-2026)
Table 23. Global Tafasitamab Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 24. Major Players of Lyophilized Powder for Injection
Table 25. Major Players of Injection Solution
Table 26. Global Tafasitamab Sales by Dosage Form (2021-2026) & (Units)
Table 27. Global Tafasitamab Sales Market Share by Dosage Form (2021-2026)
Table 28. Global Tafasitamab Revenue by Dosage Form (2021-2026) & ($ million)
Table 29. Global Tafasitamab Revenue Market Share by Dosage Form (2021-2026)
Table 30. Global Tafasitamab Sale Price by Dosage Form (2021-2026) & (US$/Unit)
Table 31. Global Tafasitamab Sale by Application (2021-2026) & (Units)
Table 32. Global Tafasitamab Sale Market Share by Application (2021-2026)
Table 33. Global Tafasitamab Revenue by Application (2021-2026) & ($ million)
Table 34. Global Tafasitamab Revenue Market Share by Application (2021-2026)
Table 35. Global Tafasitamab Sale Price by Application (2021-2026) & (US$/Unit)
Table 36. Global Tafasitamab Sales by Company (2021-2026) & (Units)
Table 37. Global Tafasitamab Sales Market Share by Company (2021-2026)
Table 38. Global Tafasitamab Revenue by Company (2021-2026) & ($ millions)
Table 39. Global Tafasitamab Revenue Market Share by Company (2021-2026)
Table 40. Global Tafasitamab Sale Price by Company (2021-2026) & (US$/Unit)
Table 41. Key Manufacturers Tafasitamab Producing Area Distribution and Sales Area
Table 42. Players Tafasitamab Products Offered
Table 43. Tafasitamab Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 44. New Products and Potential Entrants
Table 45. Market M&A Activity & Strategy
Table 46. Global Tafasitamab Sales by Geographic Region (2021-2026) & (Units)
Table 47. Global Tafasitamab Sales Market Share Geographic Region (2021-2026)
Table 48. Global Tafasitamab Revenue by Geographic Region (2021-2026) & ($ millions)
Table 49. Global Tafasitamab Revenue Market Share by Geographic Region (2021-2026)
Table 50. Global Tafasitamab Sales by Country/Region (2021-2026) & (Units)
Table 51. Global Tafasitamab Sales Market Share by Country/Region (2021-2026)
Table 52. Global Tafasitamab Revenue by Country/Region (2021-2026) & ($ millions)
Table 53. Global Tafasitamab Revenue Market Share by Country/Region (2021-2026)
Table 54. Americas Tafasitamab Sales by Country (2021-2026) & (Units)
Table 55. Americas Tafasitamab Sales Market Share by Country (2021-2026)
Table 56. Americas Tafasitamab Revenue by Country (2021-2026) & ($ millions)
Table 57. Americas Tafasitamab Sales by Type (2021-2026) & (Units)
Table 58. Americas Tafasitamab Sales by Application (2021-2026) & (Units)
Table 59. APAC Tafasitamab Sales by Region (2021-2026) & (Units)
Table 60. APAC Tafasitamab Sales Market Share by Region (2021-2026)
Table 61. APAC Tafasitamab Revenue by Region (2021-2026) & ($ millions)
Table 62. APAC Tafasitamab Sales by Type (2021-2026) & (Units)
Table 63. APAC Tafasitamab Sales by Application (2021-2026) & (Units)
Table 64. Europe Tafasitamab Sales by Country (2021-2026) & (Units)
Table 65. Europe Tafasitamab Revenue by Country (2021-2026) & ($ millions)
Table 66. Europe Tafasitamab Sales by Type (2021-2026) & (Units)
Table 67. Europe Tafasitamab Sales by Application (2021-2026) & (Units)
Table 68. Middle East & Africa Tafasitamab Sales by Country (2021-2026) & (Units)
Table 69. Middle East & Africa Tafasitamab Revenue Market Share by Country (2021-2026)
Table 70. Middle East & Africa Tafasitamab Sales by Type (2021-2026) & (Units)
Table 71. Middle East & Africa Tafasitamab Sales by Application (2021-2026) & (Units)
Table 72. Key Market Drivers & Growth Opportunities of Tafasitamab
Table 73. Key Market Challenges & Risks of Tafasitamab
Table 74. Key Industry Trends of Tafasitamab
Table 75. Tafasitamab Raw Material
Table 76. Key Suppliers of Raw Materials
Table 77. Tafasitamab Distributors List
Table 78. Tafasitamab Customer List
Table 79. Global Tafasitamab Sales Forecast by Region (2027-2032) & (Units)
Table 80. Global Tafasitamab Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Americas Tafasitamab Sales Forecast by Country (2027-2032) & (Units)
Table 82. Americas Tafasitamab Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. APAC Tafasitamab Sales Forecast by Region (2027-2032) & (Units)
Table 84. APAC Tafasitamab Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Europe Tafasitamab Sales Forecast by Country (2027-2032) & (Units)
Table 86. Europe Tafasitamab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Middle East & Africa Tafasitamab Sales Forecast by Country (2027-2032) & (Units)
Table 88. Middle East & Africa Tafasitamab Revenue Forecast by Country (2027-2032) & ($ millions)
Table 89. Global Tafasitamab Sales Forecast by Type (2027-2032) & (Units)
Table 90. Global Tafasitamab Revenue Forecast by Type (2027-2032) & ($ millions)
Table 91. Global Tafasitamab Sales Forecast by Application (2027-2032) & (Units)
Table 92. Global Tafasitamab Revenue Forecast by Application (2027-2032) & ($ millions)
Table 93. MorphoSys AG Basic Information, Tafasitamab Manufacturing Base, Sales Area and Its Competitors
Table 94. MorphoSys AG Tafasitamab Product Portfolios and Specifications
Table 95. MorphoSys AG Tafasitamab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. MorphoSys AG Main Business
Table 97. MorphoSys AG Latest Developments
Table 98. Incyte Corporation Basic Information, Tafasitamab Manufacturing Base, Sales Area and Its Competitors
Table 99. Incyte Corporation Tafasitamab Product Portfolios and Specifications
Table 100. Incyte Corporation Tafasitamab Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Incyte Corporation Main Business
Table 102. Incyte Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tafasitamab
Figure 2. Tafasitamab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tafasitamab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Tafasitamab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tafasitamab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tafasitamab Sales Market Share by Country/Region (2025)
Figure 10. Tafasitamab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Combination With Immunomodulatory Agents (Such As Lenalidomide)
Figure 12. Product Picture of Combination With Chemotherapy Or Other Targeted Therapies
Figure 13. Global Tafasitamab Sales Market Share by Type in 2026
Figure 14. Global Tafasitamab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 200 mg / vial
Figure 16. Product Picture of 800 mg/vial
Figure 17. Global Tafasitamab Sales Market Share by Specification in 2026
Figure 18. Global Tafasitamab Revenue Market Share by Specification (2021-2026)
Figure 19. Product Picture of Innovator
Figure 20. Product Picture of Generic
Figure 21. Global Tafasitamab Sales Market Share by Production Technology in 2026
Figure 22. Global Tafasitamab Revenue Market Share by Production Technology (2021-2026)
Figure 23. Product Picture of Lyophilized Powder for Injection
Figure 24. Product Picture of Injection Solution
Figure 25. Global Tafasitamab Sales Market Share by Dosage Form in 2026
Figure 26. Global Tafasitamab Revenue Market Share by Dosage Form (2021-2026)
Figure 27. Tafasitamab Consumed in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Figure 28. Global Tafasitamab Market: Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) (2021-2026) & (Units)
Figure 29. Tafasitamab Consumed in B-Cell Non-Hodgkin Lymphoma (B-NHL)
Figure 30. Global Tafasitamab Market: B-Cell Non-Hodgkin Lymphoma (B-NHL) (2021-2026) & (Units)
Figure 31. Tafasitamab Consumed in CD19-Positive Hematologic Malignancies
Figure 32. Global Tafasitamab Market: CD19-Positive Hematologic Malignancies (2021-2026) & (Units)
Figure 33. Tafasitamab Consumed in Precision Hematologic Cancer Therapy
Figure 34. Global Tafasitamab Market: Precision Hematologic Cancer Therapy (2021-2026) & (Units)
Figure 35. Tafasitamab Consumed in Others
Figure 36. Global Tafasitamab Market: Others (2021-2026) & (Units)
Figure 37. Global Tafasitamab Sale Market Share by Application (2025)
Figure 38. Global Tafasitamab Revenue Market Share by Application in 2025
Figure 39. Tafasitamab Sales by Company in 2025 (Units)
Figure 40. Global Tafasitamab Sales Market Share by Company in 2025
Figure 41. Tafasitamab Revenue by Company in 2025 ($ millions)
Figure 42. Global Tafasitamab Revenue Market Share by Company in 2025
Figure 43. Global Tafasitamab Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Tafasitamab Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Tafasitamab Sales 2021-2026 (Units)
Figure 46. Americas Tafasitamab Revenue 2021-2026 ($ millions)
Figure 47. APAC Tafasitamab Sales 2021-2026 (Units)
Figure 48. APAC Tafasitamab Revenue 2021-2026 ($ millions)
Figure 49. Europe Tafasitamab Sales 2021-2026 (Units)
Figure 50. Europe Tafasitamab Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Tafasitamab Sales 2021-2026 (Units)
Figure 52. Middle East & Africa Tafasitamab Revenue 2021-2026 ($ millions)
Figure 53. Americas Tafasitamab Sales Market Share by Country in 2025
Figure 54. Americas Tafasitamab Revenue Market Share by Country (2021-2026)
Figure 55. Americas Tafasitamab Sales Market Share by Type (2021-2026)
Figure 56. Americas Tafasitamab Sales Market Share by Application (2021-2026)
Figure 57. United States Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Tafasitamab Sales Market Share by Region in 2025
Figure 62. APAC Tafasitamab Revenue Market Share by Region (2021-2026)
Figure 63. APAC Tafasitamab Sales Market Share by Type (2021-2026)
Figure 64. APAC Tafasitamab Sales Market Share by Application (2021-2026)
Figure 65. China Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 69. India Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Tafasitamab Sales Market Share by Country in 2025
Figure 73. Europe Tafasitamab Revenue Market Share by Country (2021-2026)
Figure 74. Europe Tafasitamab Sales Market Share by Type (2021-2026)
Figure 75. Europe Tafasitamab Sales Market Share by Application (2021-2026)
Figure 76. Germany Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 77. France Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Tafasitamab Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Tafasitamab Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Tafasitamab Sales Market Share by Application (2021-2026)
Figure 84. Egypt Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Tafasitamab in 2026
Figure 90. Manufacturing Process Analysis of Tafasitamab
Figure 91. Industry Chain Structure of Tafasitamab
Figure 92. Channels of Distribution
Figure 93. Global Tafasitamab Sales Market Forecast by Region (2027-2032)
Figure 94. Global Tafasitamab Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Tafasitamab Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Tafasitamab Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Tafasitamab Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Tafasitamab Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Tafasitamab
Figure 2. Tafasitamab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tafasitamab Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Tafasitamab Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Tafasitamab Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Tafasitamab Sales Market Share by Country/Region (2025)
Figure 10. Tafasitamab Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Combination With Immunomodulatory Agents (Such As Lenalidomide)
Figure 12. Product Picture of Combination With Chemotherapy Or Other Targeted Therapies
Figure 13. Global Tafasitamab Sales Market Share by Type in 2026
Figure 14. Global Tafasitamab Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of 200 mg / vial
Figure 16. Product Picture of 800 mg/vial
Figure 17. Global Tafasitamab Sales Market Share by Specification in 2026
Figure 18. Global Tafasitamab Revenue Market Share by Specification (2021-2026)
Figure 19. Product Picture of Innovator
Figure 20. Product Picture of Generic
Figure 21. Global Tafasitamab Sales Market Share by Production Technology in 2026
Figure 22. Global Tafasitamab Revenue Market Share by Production Technology (2021-2026)
Figure 23. Product Picture of Lyophilized Powder for Injection
Figure 24. Product Picture of Injection Solution
Figure 25. Global Tafasitamab Sales Market Share by Dosage Form in 2026
Figure 26. Global Tafasitamab Revenue Market Share by Dosage Form (2021-2026)
Figure 27. Tafasitamab Consumed in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Figure 28. Global Tafasitamab Market: Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) (2021-2026) & (Units)
Figure 29. Tafasitamab Consumed in B-Cell Non-Hodgkin Lymphoma (B-NHL)
Figure 30. Global Tafasitamab Market: B-Cell Non-Hodgkin Lymphoma (B-NHL) (2021-2026) & (Units)
Figure 31. Tafasitamab Consumed in CD19-Positive Hematologic Malignancies
Figure 32. Global Tafasitamab Market: CD19-Positive Hematologic Malignancies (2021-2026) & (Units)
Figure 33. Tafasitamab Consumed in Precision Hematologic Cancer Therapy
Figure 34. Global Tafasitamab Market: Precision Hematologic Cancer Therapy (2021-2026) & (Units)
Figure 35. Tafasitamab Consumed in Others
Figure 36. Global Tafasitamab Market: Others (2021-2026) & (Units)
Figure 37. Global Tafasitamab Sale Market Share by Application (2025)
Figure 38. Global Tafasitamab Revenue Market Share by Application in 2025
Figure 39. Tafasitamab Sales by Company in 2025 (Units)
Figure 40. Global Tafasitamab Sales Market Share by Company in 2025
Figure 41. Tafasitamab Revenue by Company in 2025 ($ millions)
Figure 42. Global Tafasitamab Revenue Market Share by Company in 2025
Figure 43. Global Tafasitamab Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Tafasitamab Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Tafasitamab Sales 2021-2026 (Units)
Figure 46. Americas Tafasitamab Revenue 2021-2026 ($ millions)
Figure 47. APAC Tafasitamab Sales 2021-2026 (Units)
Figure 48. APAC Tafasitamab Revenue 2021-2026 ($ millions)
Figure 49. Europe Tafasitamab Sales 2021-2026 (Units)
Figure 50. Europe Tafasitamab Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Tafasitamab Sales 2021-2026 (Units)
Figure 52. Middle East & Africa Tafasitamab Revenue 2021-2026 ($ millions)
Figure 53. Americas Tafasitamab Sales Market Share by Country in 2025
Figure 54. Americas Tafasitamab Revenue Market Share by Country (2021-2026)
Figure 55. Americas Tafasitamab Sales Market Share by Type (2021-2026)
Figure 56. Americas Tafasitamab Sales Market Share by Application (2021-2026)
Figure 57. United States Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Tafasitamab Sales Market Share by Region in 2025
Figure 62. APAC Tafasitamab Revenue Market Share by Region (2021-2026)
Figure 63. APAC Tafasitamab Sales Market Share by Type (2021-2026)
Figure 64. APAC Tafasitamab Sales Market Share by Application (2021-2026)
Figure 65. China Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 69. India Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Tafasitamab Sales Market Share by Country in 2025
Figure 73. Europe Tafasitamab Revenue Market Share by Country (2021-2026)
Figure 74. Europe Tafasitamab Sales Market Share by Type (2021-2026)
Figure 75. Europe Tafasitamab Sales Market Share by Application (2021-2026)
Figure 76. Germany Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 77. France Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Tafasitamab Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Tafasitamab Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Tafasitamab Sales Market Share by Application (2021-2026)
Figure 84. Egypt Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Tafasitamab Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Tafasitamab in 2026
Figure 90. Manufacturing Process Analysis of Tafasitamab
Figure 91. Industry Chain Structure of Tafasitamab
Figure 92. Channels of Distribution
Figure 93. Global Tafasitamab Sales Market Forecast by Region (2027-2032)
Figure 94. Global Tafasitamab Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Tafasitamab Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Tafasitamab Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Tafasitamab Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Tafasitamab Revenue Market Share Forecast by Application (2027-2032)
